NT5E and breast cancer: The authors further hypothesized that the downregulation of CD73 observed in ER+ BC cell lines may be indirectly caused by ERs and may involve other actors, such as AP-1 and Sp1 transcription factors, which were shown to be implicated in CD73 promoter activity [87].